Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China
{{output}}
Acute myeloid leukemia (AML) can manifest as de novo AML (dn-AML) or secondary AML (s-AML), with s-AML being associated with inferior survival and distinct genomic characteristics. The underlying reasons for this disparity remain to be elucidated. In this mult... ...
